findmyKOL
Clinical trialNCT02660281CompletedPhase 1Interventional

URMC Related Haplo-identical Donor BMT

SponsorUniversity of RochesterEnrollment74Hematological DiseaseImmune DeficienciesLymphomaMultiple MyelomaMyelofibrosisSolid Tumors
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will be a single-center treatment protocol, designed to validate the process of related donor haploidentical-SCT at the Wilmot Cancer Institute Blood and Marrow Transplant Unit.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Wilmot Cancer Institute

    Rochester, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Busulfan →Fludarabine →Melphalan →Post-Stem Cell Infusion CyclophosphamidePost-Stem Cell Infusion MesnaPre-Stem Cell Infusion CyclophosphamidePre-Stem Cell Infusion MesnaThiotepa
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2015
Primary completion
28 Oct 2019
Completion
7 Jan 2021
Last update posted
3 Nov 2021
Registered enrollment
74
Registry id
NCT02660281
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.